Nicholas Investment Partners, LP

Position in ROIV — Roivant Sciences Ltd.

CIK 1389574 RANCHO SANTA FE, CA

Position in ROIV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$14,838,319

+$7,125,947 QoQ

Shares Held

419,280

+50.6% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.95%

of 13F equity value

Holder Rank

#93

of 494 holders

Holding Since

Mar 2023

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nicholas Investment Partners, LP holds $271,971,066 across 20 Biotechnology names. ROIV ranks #10 (5.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	244,594	$45,807,564
2	AXSM	Axsome Therapeutics, Inc.	98,974	$24,225,865
3	XENE	Xenon Pharmaceuticals Inc.	395,844	$23,893,143
4	BBIO	BridgeBio Pharma, Inc.	311,494	$23,200,073
5	MIRM	Mirum Pharmaceuticals, Inc.	172,695	$20,217,403
6	ELVN	Enliven Therapeutics, Inc.	391,529	$19,870,096
7	DNTH	Dianthus Therapeutics, Inc. /DE/	186,769	$18,206,242
8	CYTK	Cytokinetics Inc	209,071	$17,810,758

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,838,319	419,280	+50.6%	Shares	Sole	2026-08-14
2026-03-31	$7,712,372	278,425	-0.5%	Shares	Sole	2026-05-15
2025-12-31	$6,072,875	279,856	+13.9%	Shares	Sole	2026-02-13
2025-09-30	$3,716,245	245,621	+55.4%	Shares	Sole	2025-11-14
2023-12-31	$1,774,508	158,015	-94.7%	Shares	Sole	2024-02-08
2023-09-30	$35,018,216	2,998,135	+32.3%	Shares	Sole	2023-11-13
2023-06-30	$22,834,455	2,265,323	+111.2%	Shares	Sole	2023-08-10
2023-03-31	$7,914,186	1,072,383	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.